课题基金 / 基金详情

Acquisition of a 600 MHz NMR Spectrometer

Acquisition of a 600 MHz NMR Spectrometer
购买 600 MHz NMR 波谱仪
批准号:
9016483
负责人:
Thomas James
金额:
$50.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-02-15 至 1993-01-31

项目摘要

项目成果

Thomas James的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We propose the acquisition of a 600 MHz NMR spectrometer. The research proposed for the new instrument will improve our capability for determining high-resolution protein and nucleic acid structures in solution from two-dimensional NMR experiments and will improve our ability to elucidate protein and nucleic acid complexes. The most effective means of deriving nucleic acid and protein solution structure by using the complete relaxation matrix analysis of 2D NOE spectra to obtain numerous internuclear distances and scalar-coupling-based 2D NMR experiments to yield torsion angle constraints, in conjunction with the computational techniques of distance geometry, molecular mechanics and restrained molecular dynamics will be explored. Reverse-detection heteronuclear 2D NMR experiments will enable resonance assignments and structural insights. The improved capabilities should also aid in our studies of ligand binding to biopolymers, thus leading to greater mechanistic insights.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SBIR Phase I: Light-channeling Metamaterials for Polarimetric Sensing
  • 批准号:
    0912467
  • 项目类别:
    Standard Grant
  • 资助金额:
    $9.99万
  • 财政年份:
    2009
  • 负责人:
    Thomas James
  • 依托单位:
Acquisition of 500 MHz NMR Spectrometer
Acquisition of Equipment for 2D NMR Studies of Solution Structure
Dna Solution Structure Via Two-Dimensional Nmr
国内基金
海外基金
BRAF V600E突变型结直肠癌的免疫逃逸机制研究
  • 批准号:
    2025JJ40080
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    韩莹
  • 依托单位:
基于AI的甲状腺乳头状癌BRAFV600E基因突变和复发风险模型研究
  • 批准号:
    JCZRLH202500640
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
靶向BRAF V600E激酶分子胶降解剂的设 计合成及其作用机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    黎盛荣
  • 依托单位:
靶向PLK1通过铁死亡途径逆转BRAFV600E结直肠癌对BRAF和EGFR抑制剂耐药的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2024
  • 负责人:
    潘京华
  • 依托单位: